Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

23,630 total articles

Nature Methods Publication Reveals Deep Insights into Functional Biology through First-of-its-Kind Quantification of Tau Proteoforms

Nature Methods Publication Reveals Deep Insights into Functional Biology through First-of-its-Kind Quantification of Tau Proteoforms

Nautilus Biotechnology announced a pioneering peer-reviewed study published in Nature Methods demonstrating its Iterative Mapping technology's ability to quantify distinct tau proteoforms at single-molecule resolution. This novel measurement reveals disease-associated ordered modification patterns crucial for understanding Alzheimer's disease and r…

Rein Therapeutics to Present Late-Breaking Poster at the European Respiratory Society (ERS) 2026 Congress

Rein Therapeutics to Present Late-Breaking Poster at the European Respiratory Society (ERS) 2026 Congress

Rein Therapeutics announced it will present a late-breaking poster on LTI-03, its novel inhaled peptide therapy for idiopathic pulmonary fibrosis, at the European Respiratory Society (ERS) 2026 Congress. The presentation will detail data from the RENEW Phase 2 trial evaluating safety and efficacy of LTI-03, which aims to inhibit lung fibrosis and p…

NANO Nuclear Energy and Enveniam Sign Memorandum of Understanding to Advance U.S. Nuclear Fuel Cycle, Microreactor Deployment and Energy Infrastructure

NANO Nuclear Energy and Enveniam Sign Memorandum of Understanding to Advance U.S. Nuclear Fuel Cycle, Microreactor Deployment and Energy Infrastructure

NANO Nuclear Energy Inc., a Nasdaq-listed advanced nuclear technology company, announced a non-binding Memorandum of Understanding with Enveniam to explore collaboration on nuclear fuel transportation, conversion, microreactor commercialization, advanced manufacturing, and energy solutions for data centers and remote communities. The partnership ai…

Clearmind Medicine Signs Definitive Agreement to Acquire 51% Stake in Wireless Charging Company for Automated Parking and Robotaxis

Clearmind Medicine Signs Definitive Agreement to Acquire 51% Stake in Wireless Charging Company for Automated Parking and Robotaxis

Clearmind Medicine, a clinical-stage biotech company primarily focused on neuroplastogen therapeutics, announces an acquisition of a 51% stake in Charging Robotics, a company developing wireless EV charging solutions for automated parking and autonomous vehicles. The acquisition involves a $2.5 million purchase plus a $1.5 million loan with 4% inte…

Quantum Cyber Invites Qualified Foundries, and Prototype-Development Partners to Apply for Its Quantum-Photonic Antenna Manufacturing Program; Responses Due September 18, 2026

Quantum Cyber Invites Qualified Foundries, and Prototype-Development Partners to Apply for Its Quantum-Photonic Antenna Manufacturing Program; Responses Due September 18, 2026

Quantum Cyber N.V., a Nasdaq-listed defense technology company, announced a call for qualified manufacturing partners and applied-R&D organizations to develop a prototype of its quantum-photonic antenna front-end, aimed at enabling resilient, frequency-agile communications for unmanned aerial systems (UAS) in contested environments. This initiative…

USA Rare Earth Completes Combination with Serra Verde Group

USA Rare Earth Completes Combination with Serra Verde Group

USA Rare Earth announced the completion of its combination with Serra Verde Group, creating a global rare earths leader with a fully integrated rare earth and permanent magnet value chain spanning mining, processing, and manufacturing across the US, Brazil, and Europe. This strategic merger positions the combined company to meet growing demand for …

Lightbridge Corporation Pays Tribute to Ambassador Thomas Graham Jr., Former Executive Chairman of the Board

Lightbridge Corporation Pays Tribute to Ambassador Thomas Graham Jr., Former Executive Chairman of the Board

Lightbridge Corporation pays tribute to Ambassador Thomas Graham Jr., who served as Executive Chairman and Chairman of the board for over a decade. Ambassador Graham was renowned for his work in arms control and nuclear non-proliferation, and significantly influenced Lightbridge’s commitment to advancing nuclear fuel technology with a focus on safe…

BioStem Technologies Opens Hospital Access for VENDAJE® and VENDAJE AC® Through Vizient and Premier

BioStem Technologies Opens Hospital Access for VENDAJE® and VENDAJE AC® Through Vizient and Premier

BioStem Technologies announced that its products VENDAJE® and VENDAJE AC® are now available for order through contracts with Vizient and Premier, two of the largest Group Purchasing Organizations in the US. This expands hospital access to their BioRetain® wound care solutions, supporting broader adoption in clinical settings and advancing the compa…

POET Technologies to Exhibit at CIOE 2026, Present High-Power Laser Light Sources for AI Interconnects at IFOC

POET Technologies to Exhibit at CIOE 2026, Present High-Power Laser Light Sources for AI Interconnects at IFOC

POET Technologies announced its participation in the 2026 China International Optoelectronic Expo (CIOE) and the Infostone Optical Communication and Market Technology Conference (IFOC), where it will present its latest advancements in wafer-level chip-scale packaging technology for high-power optical interconnects. The company highlighted its progr…

INSTINCT BIO Provides Operational Update on Indonesia Growth Platform and Product Development Initiatives

INSTINCT BIO Provides Operational Update on Indonesia Growth Platform and Product Development Initiatives

Instinct Bio provided an operational update announcing progress on its GENRÊVER CLINIC site development in Jakarta, targeting a December 2026 opening, along with subscription pricing tiers. The company is also advancing product development collaborations with Invitrx Therapeutics in the US and PT Parva Candela in Indonesia to manufacture GENRÊVER-b…

VERAXA Biotech Appoints Raju Willener as Chief Financial Officer

VERAXA Biotech Appoints Raju Willener as Chief Financial Officer

VERAXA Biotech AG announces the immediate appointment of Raju Willener as Chief Financial Officer. Mr. Willener brings over 30 years of global financial leadership experience, including in corporate finance, M&A, and capital markets, across the biopharmaceutical sector. He will support VERAXA's strategic capital allocation and growth initiatives as…

Immuron to launch PROIBS® in the United States

Immuron to launch PROIBS® in the United States

Immuron Limited has signed an exclusive distribution agreement for PROIBS® in the United States, expanding its digestive health product portfolio. PROIBS®, a European-certified medical device for gut health issues such as abdominal pain and bloating, has been available in Sweden for over a decade and showed strong user satisfaction in clinical stud…

Bilibili Inc. Announces Proposed Offerings of US$700 Million Convertible Senior Notes, Concurrent Equity Placement and Concurrent Share Repurchases

Bilibili Inc. Announces Proposed Offerings of US$700 Million Convertible Senior Notes, Concurrent Equity Placement and Concurrent Share Repurchases

Bilibili Inc. has announced plans to offer $700 million in convertible senior notes due 2031, including a $200 million subscription from Tencent. Concurrently, Bilibili will conduct an equity placement involving borrowed shares and a secondary placement by Tencent, along with share repurchases totaling up to $300 million. The proceeds will be used …

LGI Homes, Inc. Reports August 2026 Home Closings

LGI Homes, Inc. Reports August 2026 Home Closings

LGI Homes, Inc. announced it closed 409 homes in August 2026, representing a 9.9% increase compared to August 2025. The company currently has 153 active selling communities and continues its growth trajectory with a strong focus on quality construction and customer service across 36 markets in 21 states.

DSS, Inc. Announces Launch of Proposed Public Offering

DSS, Inc. Announces Launch of Proposed Public Offering

DSS, Inc., a diversified multinational company listed on the NYSE American under ticker DSS, has launched a proposed public offering of its common stock to raise capital for general corporate and working capital purposes. The offering is subject to market conditions, with Aegis Capital Corp. acting as the sole book-running manager. DSS operates in …

Stoke Therapeutics and Biogen Present Long-Term Clinical Data that Support the Disease-Modifying Potential of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16th European Epilepsy Congress (EEC)

Stoke Therapeutics and Biogen Present Long-Term Clinical Data that Support the Disease-Modifying Potential of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16th European Epilepsy Congress (EEC)

Stoke Therapeutics and Biogen presented long-term clinical data at the 16th European Epilepsy Congress showing that zorevunersen, an investigational antisense oligonucleotide, produced substantial and durable reductions in seizures including severe seizure types that increase risk of SUDEP, alongside improvements in cognition, behavior, and quality…

XTEND Reality Expansion Ltd. and JFB Construction Holdings Complete Business Combination, Raising $110 Million in Total Capital

XTEND Reality Expansion Ltd. and JFB Construction Holdings Complete Business Combination, Raising $110 Million in Total Capital

XTEND AI Robotics, formed by the business combination of XTEND Reality Expansion Ltd. and JFB Construction Holdings, has successfully completed its merger and raised $110 million in total capital. The new combined company will trade on the NYSE starting September 4, 2026, under the ticker symbol XTND. With strengthened capital and a strategic focus…